ctrl K

Watchlist Price Alert

Talaris Therapeutics Inc. (TALS)

NASDAQ: TALS · Real-Time Price · USD

2.72

-0.02 (-0.73%)

At close: Oct 19, 2023, 8:00 PM

Talaris Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a
Operating Income	-76.48M	-47.51M	-22.68M	-18.38M
Interest Income	900.00	n/a	400.00	200.00
Pretax Income	-73.89M	-47.83M	-22.71M	-18.16M
Net Income	-68.73M	-48.16M	-22.73M	-17.93M
Selling & General & Admin	19.47M	13.26M	7.41M	5.01M
Research & Development	57.01M	34.24M	15.28M	13.37M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	76.48M	47.51M	22.68M	18.38M
Interest Expense	2.58M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	76.48M	47.51M	22.68M	18.38M
Income Tax Expense	-5.17M	326K	23K	-223K
Shares Outstanding (Basic)	4.12M	2.91M	668.51K	638.33K
Shares Outstanding (Diluted)	4.12M	2.91M	668.51K	638.33K
EPS (Basic)	-16.66	-16.53	-34	-28.09
EPS (Diluted)	-16.66	-16.53	-34	-28.09
EBITDA	-74.31M	-46.88M	-22.24M	-18M
EBIT	-71.31M	-48.16M	n/a	n/a
Depreciation & Amortization	2.16M	623K	447K	379K